RecruitingNot applicableNCT07428057

Postoperative Hypocalcemia After Thyroidectomy

Studying Autosomal dominant hypocalcemia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Minia University
Principal Investigator: Saleh K Saleh, MD
Minia University
Enrollment: 600 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2026 – 2026

Study locations (1)

Minia University Hospital, Minya, Minya Governorate, Egypt

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07428057 on ClinicalTrials.gov

Other trials for Autosomal dominant hypocalcemia

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2, PHASE3NCT07080385
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company
ACTIVE NOT RECRUITINGPHASE3NCT05680818
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Calcilytix Therapeutics, Inc., a BridgeBio company
ACTIVE NOT RECRUITINGNCT05227287
ADH1 and ADH2 Disease Monitoring Study (DMS)
Calcilytix Therapeutics, Inc., a BridgeBio company

See all trials for Autosomal dominant hypocalcemia →

← Back to all trials